| Title |
Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers
|
|---|---|
| Published in |
Protein & Cell, May 2019
|
| DOI | 10.1007/s13238-019-0634-z |
| Pubmed ID | |
| Authors |
Yuanlong Ge, Shu Wu, Zepeng Zhang, Xiaocui Li, Feng Li, Siyu Yan, Haiying Liu, Junjiu Huang, Yong Zhao |
Mendeley readers
The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 25 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 6 | 24% |
| Student > Master | 5 | 20% |
| Student > Bachelor | 3 | 12% |
| Researcher | 2 | 8% |
| Lecturer | 1 | 4% |
| Other | 1 | 4% |
| Unknown | 7 | 28% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 8 | 32% |
| Medicine and Dentistry | 3 | 12% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 8% |
| Agricultural and Biological Sciences | 2 | 8% |
| Linguistics | 1 | 4% |
| Other | 2 | 8% |
| Unknown | 7 | 28% |